Treatment of micturition disorders in multiple sclerosis;Tratamiento de los trastornos de la miccion en la esclerosis multiple

Neurologia

Volumn 11, Issue 5, 1996, Pages 182-191

  Bagunya Durich J ^a  

^a University Institute affiliated with the Autonomous University of Barcelona   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; BENESTAN; CAPSAICIN; DESMOPRESSIN DIACETATE; OXYBUTYNIN; PRAZOSIN; UNCLASSIFIED DRUG; VASOPRESSIN;

ARTICLE; BLADDER CATHETERIZATION; BLADDER DYSFUNCTION; DETRUSOR DYSSYNERGIA; HUMAN; INTERMITTENT CATHETERIZATION; INTRAVESICAL DRUG ADMINISTRATION; MICTURITION DISORDER; MULTIPLE SCLEROSIS; NERVE STIMULATION; NEUROGENIC BLADDER; NOCTURIA; POLLAKISURIA; URGE INCONTINENCE; URINE INCONTINENCE;

ALKALOIDS; BRAIN; CAPSAICIN; HUMANS; MULTIPLE SCLEROSIS; URINARY INCONTINENCE;

EID: 0030054741     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Miller H, Simpson CA, Yeates WK. Bladder dysfunction in multiple sclerosis. Br Med J 1965; 1: 1.265-1.269.
2. Fernández O, Luque G, San Roman C et al. The prevalence of multiple sclerosis in the sanitary district of Vélez-Málaga southern Spain. Neurology 1994; 44: 425-429.
3. Samellas W, Rubin B. Management of upper urinary tract complications in multiple sclerosis by means of diversion to an ideal conduit. J Urol 1965; 93: 548-552.
4. Betts CD, D'Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993; 56: 254-260.
5. De Groat W, Kawatani T, Hisamitsu T. Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Autonom Nerv Syst 1990; 30: 571-578.
6. Blaivas JG, Kaplan SA. Urologic dysfunction in patients with multiple sclerosis. Semin Neurology 1988; 8: 2.
7. Fowler CJ, Van Kerrebroek EV, Nordenbo A et al. Treatment of lower urinary tract dysfunction in patients with multple sclerosis. J Neurol Neurosurg Psychiatry 1992; 55: 986-989.
8. Anderson JT, Bradley WE. Abnormalities of detrusor and sphincter function in multiple sclerosis. J Urol 1981; 48: 193-198.
9. May ME, Chetner MP. Lower urinary tract dysfunction in multiple sclerosis. Urology 1992; 39: 67-70.
10. Wagner M. Ultrasound evolution. Modern Healthcare, 1992.
11. Blaivas JG. Evaluation of urinary bladder symptoms in multiple sclerosis. En: Poser CM, Paty DW, McDonald WI, Scheinberg I, Ebers GC, editores. The diagnosis of multiple sclerosis. Nueva York: Thieme-Stratton, 1984; 76-93.
12. Valiquette G, Abrams GM, Herbert J. DDAVP in the management of nocturnal incontinence in multiple sclerosis. Neurology 1990; 40 (Supl 1): 260.
13. Eckford SD, Carter PG, Jackson SR et al. An open, inpatient incremental safety and efficacy study of desmopressin in women with multiple sclerosis and nocturia. Br J Urol 1995; 76: 459-463.
14. Fowler CJ, Beck RO, Gerrard S et al. Intravesical capsaicin for treatment of detrussor hyperreflexia. J Neurol Neurosurg Psychiatry 1994; 57: 169-173.
15. Nitti V. Intravesical capsaicin for treatment of neurogenic bladder. Lancet 1994; 343.
16. Madersbacher H. Control of detrussor hyperreflexia by the intravesical instillation of oxybutynine hydrochloride. Paraplegia 1991; 29: 84-90.
17. Madersbacher H. The various types of neurogenic bladder dysfunction: an update of current therapeutic concepts. Paraplegia 1990; 28: 217-229.
18. Kuhn W, Rist M, Zaech GA. Intermitent urethral self-catheterization: long term results (bacteriological evolution, continence, acceptance, complications). Paraplegia 1991; 29: 222-232.
19. Chancellor MB, Ribas DA, Linsenmeyer T et al. Multicenter trial in North America of urolume urinary sphincter prothesis. J Urol 1994; 152: 924-930.
20. Benchekroun. Continent caecal bladder. Br J Urol 1982; 54: 505.
21. Barnes DG, Shaw PJR, Timoney AG et al. Management of neuropathic bladder by suprapubic catheterization. Br J Urol 1993; 72: 169-172.
22. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993; 329: 1.328-1.334.
23. Hawkes CH, Bears R, Fawcett D et al. Dorsal column stimulation in multiple sclerosis: effects on bladder and long term findings. Br Med J 1983; 287: 793-795.
24. Sibley WA, Bauer HJ, Johnson KP et al. Therapeutic claims in multiple sclerosis. Nueva York: Demos Publications, 1988.
25. Van Poppel H, Ketelaer P, Van DeWeerd A. Interferential therapy for detrusor hyperreflexia in multiple sclerosis. Urology 1985; 25: 607-612.
26. Henderson JS. A pubococcygeal exercise program for simple urinary stress incontinence: applicability to the female client with multiple sclerosis. J Neuroscience Nurs 1988; 20: 185-188.
27. Maggi CA, Santicioli P, Borsini F et al. The role of the capsaicin-sensitive innervation of the rat urinary bladder in the activation of micturition reflex. Naunyn-Schmiedeberg's Arch Pharmacol 1986; 322: 276-283.
28. Madersbacher H, Fisher J. Sacral anterior root stimulator: prerequisites and indications. Neurourol Urodyn 1993; 12: 489-494.
29. Sarrias M, Sarrias F, Borau A. The Barcelona technique. Neurourol Urodyn 1993; 12: 495-496.
30. Brindley GS. The first 500 patients with sacral anterior root stimulator implants: general description. Paraplegia 1994; 32: 795-805.